Marina Biotech (Nasdaq MRNA) is a biotechnology company with offices in Bothell, WA andCambridge, MA, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). Marina is building cutting-edge drug discovery and development platforms based on the premise that no single RNAi technology or delivery approach can be broadly applied to the treatment of all human diseases.
Marina is currently employing two RNAi platforms to down-regulate the expression of specific proteins that cause disease:
- TauRNAi which is a combination of Marina’s proprietary UsiRNA technology for the construction of small interfering RNA (siRNA) and the novel dialkylated amino acid-based liposome (DiLA2) delivery system
- TransKingdom RNAi™, or tkRNAi, which is an expressed RNA in a bacterial delivery system.
For more information visit: http://www.marinabio.com/
Biota Biosciences is an innovative biotech company developing new solutions for production of foods. Biota’s expertise lies in providing specialized products for the livestock industry to improve animal health, increase food supply and reduce costs and environmental impact of food production. ViThera collaborates with Biota on projects that decrease the need for antibiotics in poultry and increase the efficiency of feed utilization.
For more information visit: www.biotabiosci.com